These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 882960)

  • 41. Inhibitory effects of H2-receptor antagonists on platelet function in vitro.
    Nakamura K; Kariyazono H; Shinkawa T; Yamaguchi T; Yamashita T; Ayukawa O; Moriyama Y; Yotsumoto G; Toyohira H; Taira A; Yamada K
    Hum Exp Toxicol; 1999 Aug; 18(8):487-92. PubMed ID: 10462360
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Platelet aggregation in asthma].
    Palma-Carlos ML; Santos MC; Palma-Carlos AG
    Allerg Immunol (Paris); 1989 May; 21(5):177-82. PubMed ID: 2500134
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phenylbutazone inhibition of equine platelet function.
    Meyers KM; Lindner C; Katz J; Grant B
    Am J Vet Res; 1979 Feb; 40(2):265-70. PubMed ID: 464364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Platelet antiaggregating activity of imolamine: in vitro studies.
    Tremoli E; Maderna P; Cocuzza E; Mantero O
    Pharmacol Res Commun; 1979 Jan; 11(1):31-8. PubMed ID: 424437
    [No Abstract]   [Full Text] [Related]  

  • 45. Endothelin and platelet function.
    Ohlstein EH; Storer B; Nambi P; Given M; Lippton H
    Thromb Res; 1990 Mar; 57(6):967-74. PubMed ID: 2116686
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Altered platelet function in diabetes mellitus.
    Colwell JA; Halushka PV; Sarji K; Levine J; Sagel J; Nair RM
    Diabetes; 1976; 25(2 SUPPL):826-31. PubMed ID: 823064
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet storage pool deficiency and prostaglandin synthesis in chronic granulocytic leukaemia.
    Gerrard JM; Stoddard SF; Shapiro RS; Coccia PF; Ramsay NK; Nesbit ME; Rao GH; Krivit W; White JG
    Br J Haematol; 1978 Dec; 40(4):597-607. PubMed ID: 281970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of N-acetylglucosamine and platelet inhibitors on the synergistic interaction of platelets and aggregating agents in the presence of wheat germ agglutinin.
    Tandon NN; Ordinas A; Jamieson GA
    Biochim Biophys Acta; 1982 Nov; 719(2):388-95. PubMed ID: 6817815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mitoxantrone and bisantrene inhibition of platelet aggregation and prostaglandin E2 production in vitro.
    Frank P; Novak RF
    Biochem Pharmacol; 1985 Oct; 34(19):3609-14. PubMed ID: 3863620
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of raubasine and pipratecol on platelet aggregation and on the platelet release reaction].
    Cattaneo M; D'Angelo A; Mannucci PM; Pareti F; Vanasia S; Viganò
    Clin Ter; 1980 Feb; 92(4):359-68. PubMed ID: 6108818
    [No Abstract]   [Full Text] [Related]  

  • 51. Potentiation of platelet responses in vitro by feline infectious peritonitis virus.
    Boudreaux MK; Weiss RC; Toivio-Kinnucan M; Spano JS
    Vet Pathol; 1990 Jul; 27(4):261-8. PubMed ID: 2144930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence for the mechanism by which eicosapentaenoic acid inhibits human platelet aggregation and secretion - implications for the prevention of vascular disease.
    Jakubowski JA; Ardlie NG
    Thromb Res; 1979; 16(1-2):205-17. PubMed ID: 388720
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis.
    Di Minno G; Martinez J; McKean ML; De La Rosa J; Burke JF; Murphy S
    Am J Med; 1985 Nov; 79(5):552-9. PubMed ID: 3933340
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Arginine vasopressin release from human platelets after irreversible aggregation.
    Anfossi G; Mularoni E; Trovati M; Massucco P; Mattiello L; Emanuelli G
    Clin Sci (Lond); 1990 Jan; 78(1):113-6. PubMed ID: 2153488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Platelet function in the neonate.
    Stuart MJ
    Am J Pediatr Hematol Oncol; 1979; 1(3):227-34. PubMed ID: 543516
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aggregation characteristics of platelets in stored concentrates of human blood.
    Nolan ML; Harrington MG
    Biochem Soc Trans; 1995 May; 23(2):373S. PubMed ID: 7672404
    [No Abstract]   [Full Text] [Related]  

  • 58. Whole blood platelet aggregation in humans and animals: a comparative study.
    Soloviev MV; Okazaki Y; Harasaki H
    J Surg Res; 1999 Apr; 82(2):180-7. PubMed ID: 10090827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro enhancement of human platelet aggregation by somatostatin.
    Gazzaniga PP; Di Macco G; La Mancusa R; Oddi A; Pappalardo G; Pulcinelli FM; Reggio D
    Experientia; 1988 Oct; 44(10):892-4. PubMed ID: 2903069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acquisition and aggregation of canine blood platelets: basic mechanisms of function and differences because of breed origin.
    Clemmons RM; Meyers KM
    Am J Vet Res; 1984 Jan; 45(1):137-44. PubMed ID: 6422804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.